Zoledronic acid
Aclasta, Zerlinda, Zometa
Revu par Sid DajaniDernière mise à jour par Michael Stewart, MRPharmSDernière mise à jour 19 juil. 2023
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Version audio
Zoledronic acid is given by intravenous infusion in a hospital setting.
You will be asked to drink several glasses of water during treatment to make sure that you are not dehydrated.
Your doctor may recommend that you see your dentist before receiving this treatment.
Dans cet article:
Sélections de vidéos pour Traitement de la douleur musculaire, osseuse et articulaire
Continuez à lire ci-dessous
About zoledronic acid
Type de médicament | Bisphosphonate |
Utilisé pour | Osteoporosis; Paget's disease of bone; bone problems associated with some cancers |
Aussi appelé | Aclasta®; Zerlinda®; Zometa® |
Disponible sous forme de | Injection |
Zoledronic acid, a bisphosphonate, is prescribed for the treatment of a number of different problems which affect bones. It is prescribed as a treatment for ostéoporose, and it is also used to prevent bone damage in people with Maladie osseuse de Paget. It is also given as a treatment for people with some cancers in order to reduce bone damage and blood calcium levels.
Osteoporosis is a bone disease which causes bones to become brittle and fragile, making them prone to breaks and fractures. During our lifetime, old bone tissue is constantly being broken down and replaced by new bone. As we get older, our bone begins to lose density because old bone is lost faster than new bone can replace it. Zoledronic acid slows down the rate at which old bone is lost and this leads to an overall increase in bone density.
In Paget's disease of bone, zoledronic acid works on bones to make them stronger and help prevent bone thickening. This helps ease symptoms such as pain, bone damage and fracture.
In some cancers there can be an excessive breakdown of bone. As this happens, calcium is lost from the bone and seeps into the blood, leading to higher than normal levels of calcium in the blood. This is called hypercalcaemia. Zoledronic acid binds to bone and reduces the rate at which it is broken down. This helps to strengthen bones and prevents the loss of calcium. This in turn reduces the high levels of calcium in the blood.
Before having zoledronic acid
Retour au sommaireSome medicines are not suitable for people with certain conditions, and sometimes a medicine may only be used if extra care is taken. For these reasons, before you start treatment it is important that your doctor knows:
If you are pregnant or breastfeeding. Zoledronic acid is not suitable for women who could become pregnant.
If you are due to have any dental treatment in the near future, or if you have pas recently had a dental check-up.
Si vous avez une maladie cardiaque.
If you have any problems with the way your kidneys work, or with the way your liver works.
Si vous prenez d'autres médicaments. Cela inclut tous les médicaments que vous prenez et qui sont disponibles à l'achat sans ordonnance, ainsi que les médicaments à base de plantes et les médecines complémentaires.
Si vous avez déjà eu une réaction allergique à un médicament.
Continuez à lire ci-dessous
How you will be given zoledronic acid
Retour au sommaireBefore you start the treatment, ask to read the manufacturer's printed information leaflet from inside the pack. It will give you more information about zoledronic acid and will provide you with a full list of the side-effects which you may experience from having it.
Zoledronic acid will be given to you in a hospital clinic. It will be administered by intravenous infusion - this means that it is injected slowly (over 15 minutes or so) into one of your veins.
The number of doses you will be given will depend upon the reason why it has been prescribed for you. Many people require only a single dose, although repeat doses can be required for people with osteoporosis and in some cancers.
Tirer le meilleur parti de votre traitement
Retour au sommaireIt is important that you do not become dehydrated during treatment with zoledronic acid. Your doctor will advise how much water you need to drink - this is usually one or two large glassfuls before and after treatment.
If you have osteoporosis or Paget's disease of bone, it may be necessary for you to take supplements of calcium and vitamin D alongside this treatment. If so, your doctor will prescribe these for you.
Good dental hygiene is important during treatment with this medicine - this means that you must brush your teeth regularly and have regular dental check-ups. You should also make sure that your dentist is aware that you have had zoledronic acid, as some dental treatments may not be recommended for you.
Remember to keep your regular appointments with your doctor so that your progress can be monitored. You may need to have blood tests following this treatment.
You should avoid becoming pregnant whilst you are being treated with zoledronic acid. Make sure you have discussed with your doctor which types of contraception are suitable for you and your partner.
Continuez à lire ci-dessous
Can zoledronic acid cause problems?
Retour au sommaireAlong with their useful effects, most medicines can cause unwanted side-effects although not everyone experiences them. The table below contains some of the most common ones associated with zoledronic acid. You will find a full list in the manufacturer's information leaflet supplied with your medicine. The unwanted effects often improve as your body adjusts to the new medicine, but speak with your doctor or pharmacist if any of the following continue or become troublesome.
Common side-effects (these affect fewer than 1 in 10 people) | Que puis-je faire si je ressens cela ? |
Conjunctivitis, feeling dizzy | Take care, especially if using tools or machines |
Feeling sick (nausea) or being sick (vomiting), gastrointestinal upset | Stick to simple foods and drink plenty of water to replace any lost fluids |
Headache, high temperature (fever), aches and pains, flu-like symptoms | Ask your doctor or pharmacist to recommend a suitable painkiller, and take plenty of rest and fluids |
Changes in heart rhythm and changes to some blood test results | Your doctor will monitor for these |
Swelling or pain at the infusion site | Cela devrait bientôt passer |
Less common, but possibly serious, side-effects | What should I do if I experience this? |
Pain in your thigh, hip, or groin | Speak with your doctor as soon as possible - these can be signs of a thighbone fracture |
A loose tooth, or jaw pain with swelling or numbness | Speak with your doctor as soon as possible - these can be signs of a problem called osteonecrosis of the jaw |
Ear pain, discharge from an ear, ear infection | These could be signs of a problem called osteonecrosis of the ear. Speak with your doctor straightaway |
Si vous ressentez d'autres symptômes que vous pensez être dus au médicament, parlez-en à votre médecin ou à votre pharmacien pour obtenir des conseils supplémentaires.
Informations importantes sur tous les médicaments
Retour au sommaireInformations importantes sur tous les médicaments
Si vous achetez des médicaments, vérifiez avec un pharmacien qu'ils sont sûrs à prendre avec vos autres médicaments.
Si vous subissez une opération ou un traitement dentaire, informez la personne qui effectue le traitement des médicaments que vous prenez.
Always read the printed information leaflet that comes with your medicine.
Si vous avez des questions concernant ce médicament, demandez à votre pharmacien.
Signaler les effets secondaires d'un médicament ou d'un vaccin
Si vous ressentez des effets secondaires, vous pouvez les signaler en ligne via le site web Yellow Card.

Vous n'êtes pas sûr de mélanger des médicaments ?
Vérifiez les interactions possibles entre les médicaments, les compléments et les aliments avant de les prendre ensemble.
Lectures complémentaires et références
- Manufacturer's PIL, Aclasta® 5 mg solution for infusion; Novartis Pharmaceuticals UK Ltd, The electronic Medicines Compendium. Dated December 2022.
- Manufacturer's PIL, Zometa® 4 mg/5 ml Concentrate for Solution for Infusion; Phoenix Labs Ltd, The electronic Medicines Compendium. Dated May 2021.
- Médicaments Complets BNF 89e Édition; Association Médicale Britannique et Société Royale Pharmaceutique de Grande-Bretagne, Londres.
Continuez à lire ci-dessous
Historique de l'article
Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
Prochaine révision prévue : 18 juil. 2026
19 Jul 2023 | Dernière version

Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.